In This Article

The short answer: Most body composition scans and smart scales report a raw muscle mass number in kilograms or pounds. That number alone tells you very little, because a taller person needs more muscle just to move their own frame. The metric researchers actually use is a muscle mass index: total appendicular muscle mass divided by your height squared, the same normalization trick BMI uses for weight. Indexing to height is what turns a body composition readout into a number that predicts strength and functional risk, and it is the number most consumer apps never show you.

Read key takeaways →

What muscle mass index actually means

A muscle mass index takes the muscle in your arms and legs, called appendicular skeletal muscle mass because it sits in the limbs rather than the trunk, and divides it by your height in meters squared. Researchers call this appendicular skeletal muscle mass index, or ASMI (also written SMI). The formula looks identical to body mass index, just with muscle mass swapped in for total body weight: ASMI = appendicular muscle mass (kg) / height (m)².

The reason this specific measurement became the research standard traces back to Richard Baumgartner and colleagues' 1998 study in the American Journal of Epidemiology, which analyzed body composition data from the New Mexico Elder Health Survey. Baumgartner's team proposed defining sarcopenia, the age-related loss of muscle, the same way clinicians define obesity: as a value more than two standard deviations below the mean of a young, healthy reference population. That framework, height-normalized muscle mass compared to a reference range, is still the backbone of how muscle mass is interpreted today.

The Formula

ASMI = Appendicular Muscle Mass (kg) ÷ Height² (m²)

Appendicular muscle mass is the muscle in both arms and both legs, measured by a DEXA scan or estimated by a bioelectrical impedance device. Trunk muscle is left out because limb muscle is what most closely tracks with functional strength.

Why the index matters more than the raw number

A smart scale or InBody printout that reports "62 lbs of muscle mass" is not wrong, but it is not comparable across people, or even across your own body if your height is part of the picture. A 6-foot-2 person and a 5-foot-4 person can carry the same total muscle mass and be in very different positions relative to what is healthy for their frame, the same reason two people at the same body weight can have very different BMIs.

Indexing to height also matters when you track your own training progress over time. Raw muscle mass in kilograms will drift with hydration, glycogen stores, and measurement error from one scan to the next. The index does not remove that noise, but because it is the version validated against real outcomes like grip strength and mobility, it is the number worth anchoring to rather than the raw kilogram figure alone.

Raw Muscle Mass

  • Reported in kg or lbs on most scales and scans
  • Not adjusted for how tall you are
  • Two people at very different heights can share the same number and be in different situations

Muscle Mass Index (ASMI)

  • Muscle mass divided by height squared
  • The version used in the research that defines low-muscle cutoffs
  • Comparable across people of different heights

How researchers set reference ranges

Baumgartner's 1998 paper proposed specific cutoffs for classifying low muscle mass: an ASMI below 7.26 kg/m² for men and below 5.45 kg/m² for women, each set at two standard deviations below the mean of a young reference group. Those numbers came from one regional U.S. population and were never meant to be a universal cutoff for everyone, but they became the reference point that later, larger consensus efforts built on and refined.

The Foundation for the National Institutes of Health (FNIH) Sarcopenia Project took a different approach in a 2014 analysis led by Stephanie Studenski, published in The Journals of Gerontology: Series A. Instead of comparing muscle mass to a young reference group, the FNIH team pooled data from over 26,000 older adults and looked for the muscle mass cutpoint that best predicted clinically meaningful weakness, defined as a grip strength below 26 kg in men and below 16 kg in women. They recommended indexing appendicular lean mass to body mass index rather than height, with cutpoints below 0.789 in men and below 0.512 in women, arguing this tracked functional weakness more closely than a height-based index alone.

The European Working Group on Sarcopenia in Older People published a revised consensus in 2019, led by Alfonso Cruz-Jentoft in Age and Ageing, known as EWGSOP2. Rather than starting from a muscle mass cutoff, EWGSOP2 flags a person as having probable sarcopenia based on low grip strength first (below 27 kg in men, below 16 kg in women), then confirms the diagnosis with a low muscle mass or quality measurement from a DEXA or bioelectrical impedance scan, and calls it severe if gait speed also falls to 0.8 meters per second or below. The Asian Working Group for Sarcopenia published its own 2019 update, led by Liang-Kung Chen in the Journal of the American Medical Directors Association, using population-specific cutoffs because the original New Mexico-derived values did not transfer cleanly to Asian populations.

Baumgartner et al. (1998), ASMI

Below 7.26 kg/m² (men) or 5.45 kg/m² (women): more than 2 SD below a young reference group. The original height-normalized cutoff.

FNIH Sarcopenia Project (2014), ALM/BMI

Below 0.789 (men) or 0.512 (women): the cutpoint found to best predict clinically significant weakness in a pooled sample of over 26,000 older adults.

EWGSOP2 (2019), grip strength first

Below 27 kg (men) or 16 kg (women) flags probable sarcopenia; muscle mass scanning then confirms it rather than leading the diagnosis.

These are clinical research cutoffs built for identifying sarcopenia risk in older adults, not fitness benchmarks for a healthy younger adult optimizing training. A younger, active person's number sitting well above these thresholds says only that they are not in the range associated with age-related muscle loss. It does not, by itself, rank how strong or muscular they are relative to other healthy adults.

How muscle mass index actually gets measured

The reference method is a DEXA scan (dual-energy X-ray absorptiometry), the same scan used to measure bone density, which separates the body into fat, lean, and bone mass by region. Nearly all of the cutoffs described above, including Baumgartner's original work and the FNIH project, were built on DEXA data.

Consumer devices, including the bioelectrical impedance (BIA) scales and handheld analyzers most people actually have access to, estimate muscle mass indirectly by sending a weak electrical current through the body and inferring composition from how much resistance it meets. A 2021 validation study by Yosuke Yamada and colleagues in the Journal of Cachexia, Sarcopenia and Muscle compared DEXA and BIA measurements against four different international sarcopenia cutoff systems in a Japanese population and found that which method you use, and which cutoff set you apply it to, changes who gets classified as low muscle mass. BIA devices are a reasonable way to track your own trend over time on the same machine, but the absolute number is not interchangeable with a DEXA-derived one, and switching devices mid-tracking can look like a real change in muscle mass when it is really a change in method.

DEXA Scan

  • Direct measurement using X-ray absorption
  • The reference standard behind the research cutoffs above
  • Requires a clinic, gym, or imaging center visit

BIA Scale or Handheld

  • Estimates composition from electrical resistance
  • Convenient for frequent, at-home tracking
  • Numbers vary by device and are not directly interchangeable with DEXA

The common misconception

A high muscle mass index is not the same thing as being strong. The index measures how much muscle tissue you carry relative to your height, while strength depends on neuromuscular factors like motor unit recruitment and technique that a body composition scan cannot see. Someone can carry more muscle mass than another person and still produce less force in a given lift.

This is exactly why EWGSOP2 leads with a grip strength test rather than a muscle mass scan: muscle quantity and muscle function are correlated but not identical, and the consensus groups that study this closely treat a strength test like grip strength as the more direct signal of functional risk. A muscle mass index is best read as one input describing your body composition, not a standalone verdict on how strong or capable you are.

What to actually do with your number

1

Track the trend on one device, not the absolute number. Because BIA estimates vary by brand and algorithm, the direction of change over months on the same scale or scanner is more meaningful than comparing your figure to a chart built from a different measurement method.

2

Pair it with a strength measurement. Grip strength or a tracked lift gives you the functional half of the picture that a muscle mass index alone cannot provide.

3

Get a DEXA scan occasionally for a true baseline. Even once a year, a DEXA reading gives you a reference point to sanity-check what your at-home BIA device is reporting.

4

Prioritize resistance training and adequate protein. These are the two levers with the most consistent research support for building and preserving appendicular muscle mass, well ahead of anything a tracking device changes on its own.

5

Do not self-diagnose sarcopenia from an app number. The clinical cutoffs above come from specific reference populations and are meant to be applied by a clinician alongside a strength and mobility assessment, not read off a consumer scale in isolation.

Frequently asked questions

What is a good muscle mass index?

There is no single universal target. Research cutoffs like Baumgartner and colleagues' 7.26 kg/m² (men) and 5.45 kg/m² (women) mark the low end associated with age-related muscle loss, not an ideal to aim for. A healthy, active adult's number will typically sit well above these thresholds, and the more useful comparison is your own trend over time rather than a fixed target.

Why does my smart scale not show a muscle mass index?

Most consumer scales report raw muscle mass or a muscle percentage because it is simpler to display, even though the height-normalized index is what the research cutoffs are actually built around. You can calculate it yourself by dividing the appendicular or total muscle mass figure by your height in meters squared, keeping in mind that most published cutoffs use appendicular (limb) muscle mass specifically, not whole-body muscle mass.

Is BIA muscle mass accurate enough to trust?

It is reasonable for tracking your own trend on the same device, but Yamada and colleagues' 2021 validation study found that BIA and DEXA measurements do not always agree, and which sarcopenia cutoff system you apply changes the classification. Treat a BIA number as an estimate, not a lab-grade measurement.

Why does EWGSOP2 test grip strength before muscle mass?

Because the 2019 EWGSOP2 consensus, led by Alfonso Cruz-Jentoft, found that low muscle strength is a more direct and practical first signal of functional risk than muscle quantity. Muscle mass scanning is used afterward to confirm the diagnosis, not to make the initial call.

Can you have a normal muscle mass index and still be weak?

Yes. Muscle mass and muscle strength are related but distinct, since strength also depends on neuromuscular factors a body composition scan does not capture. This is part of why grip strength and other functional tests are tracked alongside, not instead of, a muscle mass index.

Do these cutoffs apply to younger, healthy adults?

Not directly. The cutoffs from Baumgartner et al. (1998), the FNIH Sarcopenia Project (2014), and EWGSOP2 (2019) were developed and validated in older adult populations to flag sarcopenia risk. A younger adult optimizing training is better served by tracking their own muscle mass trend alongside strength performance than by comparing against a threshold built for a different age group.

What to Remember

  • →Muscle mass index (ASMI) divides appendicular muscle mass by height squared, the same normalization approach BMI uses for weight, which is why it compares better across people than a raw kilogram figure.
  • →Baumgartner and colleagues' 1998 study set the original cutoffs (below 7.26 kg/m² in men, 5.45 kg/m² in women) that later consensus groups like the FNIH Sarcopenia Project (2014) and EWGSOP2 (2019) built on and refined.
  • →EWGSOP2 leads with a grip strength test, not a muscle mass scan, because muscle quantity and muscle function are correlated but not the same thing.
  • →DEXA is the reference measurement behind these cutoffs. Consumer BIA scales estimate muscle mass indirectly and can disagree with DEXA, so track the trend on one device rather than comparing absolute numbers across methods.
  • →These cutoffs were built to flag sarcopenia risk in older adults. They are a reference point, not a target, for a younger adult optimizing training.

Related on Protocol

LearnTraining

Why Muscle Mass Is Your Best Longevity Metric (More Than Weight or BMI)

The broader case for tracking muscle mass over the years, beyond a single index cutoff.

Read
LearnHealth

What Grip Strength Tells You About Longevity and Nervous System Health

The functional strength test that consensus groups use alongside a muscle mass index.

Read
LearnNutrition

How Much Protein You Actually Need for Fat Loss, Muscle Gain, and Longevity

The nutrition lever most directly tied to building and preserving the muscle mass this index measures.

Read

See your body composition trend alongside training and recovery

Protocol tracks your body composition readings over time next to your training load and recovery data, so a single scan or scale reading is never read in isolation.

Get started free

References

Key Researchers

  • Richard Baumgartner Led the 1998 study that proposed the original height-normalized muscle mass index and cutoffs still referenced in sarcopenia research today.
  • Alfonso Cruz-Jentoft Led the 2019 EWGSOP2 consensus that redefined sarcopenia diagnosis around strength testing first, muscle mass measurement second.

Key Studies

  • Baumgartner et al. (1998) American Journal of Epidemiology. Defined appendicular skeletal muscle mass index (ASMI) using New Mexico Elder Health Survey data and proposed cutoffs of 7.26 kg/m² (men) and 5.45 kg/m² (women), two standard deviations below a young reference group.
  • Studenski et al. (2014) The Journals of Gerontology: Series A. The FNIH Sarcopenia Project analysis of over 26,000 older adults, proposing appendicular lean mass adjusted for BMI cutpoints (below 0.789 in men, 0.512 in women) tied to clinically significant weakness.
  • Cruz-Jentoft et al. (2019) Age and Ageing. The EWGSOP2 revised European consensus on sarcopenia diagnosis, using grip strength (below 27 kg men, 16 kg women) as the initial screen and muscle mass scanning to confirm.
  • Chen et al. (2020) Journal of the American Medical Directors Association. The Asian Working Group for Sarcopenia 2019 consensus update, applying population-specific cutoffs rather than the original New Mexico-derived values.
  • Yamada et al. (2021) Journal of Cachexia, Sarcopenia and Muscle. Validated four international sarcopenia muscle mass cutoff systems against DEXA and BIA measurements in a Japanese population, finding meaningful disagreement between measurement methods.

Apps and Tools

  • Protocol Tracks body composition readings over time alongside training load and recovery, so a single scan or scale reading is read in context.